MXPA92003517A - Colestiramina como productos que contienen agentes bajo contenido de lipidos. - Google Patents
Colestiramina como productos que contienen agentes bajo contenido de lipidos.Info
- Publication number
- MXPA92003517A MXPA92003517A MXPA92003517A MX9203517A MXPA92003517A MX PA92003517 A MXPA92003517 A MX PA92003517A MX PA92003517 A MXPA92003517 A MX PA92003517A MX 9203517 A MX9203517 A MX 9203517A MX PA92003517 A MXPA92003517 A MX PA92003517A
- Authority
- MX
- Mexico
- Prior art keywords
- colestyramine
- products containing
- microtablets
- lowering agents
- containing lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La colestiramina como productos que contienen agentes de bajo contenido de lipidos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3930168A DE3930168A1 (de) | 1989-09-09 | 1989-09-09 | Verbesserte verabreichungsform fuer colestyramin |
| PCT/EP1990/001514 WO1991003249A1 (de) | 1989-09-09 | 1990-09-07 | Colestyramin als lipidsenker enthaltende präparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA92003517A true MXPA92003517A (es) | 2004-03-04 |
Family
ID=6389097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA92003517A MXPA92003517A (es) | 1989-09-09 | 1990-09-07 | Colestiramina como productos que contienen agentes bajo contenido de lipidos. |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE3930168A1 (es) |
| MX (1) | MXPA92003517A (es) |
| ZA (1) | ZA907130B (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2637668B1 (en) | 2010-11-08 | 2016-05-11 | Albireo AB | Ibat inhibitors for the treatment of liver diseases |
| JP6751020B2 (ja) | 2014-06-25 | 2020-09-02 | Ｅａファーマ株式会社 | 固形製剤及びその着色防止又は着色低減方法 |
| EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| CA3011565C (en) * | 2016-02-09 | 2024-01-02 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| RU2750937C2 (ru) * | 2016-02-09 | 2021-07-06 | Альбирео Аб | Пероральный состав холестирамина и его применение |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| WO2019032026A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | CHOLESTYRAMINE GRANULES, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE |
| WO2019032027A1 (en) * | 2017-08-09 | 2019-02-14 | Albireo Ab | CHOLESTYRAMINE TABLETS, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE |
| CA3100113A1 (en) | 2018-06-05 | 2019-12-12 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| KR20210024033A (ko) | 2018-06-20 | 2021-03-04 | 알비레오 에이비 | 오데빅시바트의 약학 제제 |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| JP2023504647A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| ES2973355T3 (es) | 2019-12-04 | 2024-06-19 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| ES2973549T3 (es) | 2019-12-04 | 2024-06-20 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores de los ácidos biliares |
| CA3158184A1 (en) | 2019-12-04 | 2021-08-10 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| CN116157389A (zh) | 2020-08-03 | 2023-05-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
| BR112023010799A2 (pt) | 2020-12-04 | 2023-10-03 | Albireo Ab | Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares |
-
1989
- 1989-09-09 DE DE3930168A patent/DE3930168A1/de not_active Withdrawn
-
1990
- 1990-09-07 MX MXPA92003517A patent/MXPA92003517A/es unknown
- 1990-09-07 ZA ZA907130A patent/ZA907130B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3930168A1 (de) | 1991-03-14 |
| ZA907130B (en) | 1992-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA92003517A (es) | Colestiramina como productos que contienen agentes bajo contenido de lipidos. | |
| DE3688075D1 (de) | Transdermales verabreichungssystem. | |
| AU3502289A (en) | Method for administering the drug deprenyl so as to minimize the danger of side effects | |
| GB2203338B (en) | Dosage form comprising parallel laminae | |
| FR2512670B1 (fr) | Capsules contenant le principe actif d'un allergene et procede pour leur preparation | |
| DE3853191D1 (de) | Arzneimittelträger. | |
| YU46701B (sh) | Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance | |
| EP0274431A3 (en) | Drug delivery compositions and methods | |
| MY101544A (en) | Pharmaceutical composition for external use containing active-type vitamin d3. | |
| JPS6485984A (en) | Methylenephosphonoalkylphosphinates, medicinal composition and therapy for abnormal calcium and phosphate metabolism | |
| DE3575076D1 (de) | Katheter fuer rueckinfusion von pharmazeutischen agenten. | |
| DE3173892D1 (en) | Insecticidal (1,1'-biphenyl)-3-ylmethyl esters, their production and use and compositions containing them | |
| DK360188D0 (da) | Laegemiddelafgivelsesorgan | |
| GR3019171T3 (en) | System for delivering drug with enhanced bioacceptability. | |
| DE3880667D1 (de) | Ampulle zur gesteuerten verabreichung eines heilmittels. | |
| JPS56154417A (en) | Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it | |
| IL86395A (en) | Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil | |
| FR2585572B3 (fr) | Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse | |
| AU2072088A (en) | Agent containing salicylic acid for treating lepidosis | |
| BE902796A (fr) | Ester d'acetyl carnitine, sa preparation et son utilisation. | |
| DE59001121D1 (en) | Antacidatabletten. | |
| ATE140592T1 (de) | Nährstoff- und arzneimittelzubereitungen auf der basis von chitosan für die verabreichung an wiederkäuer | |
| EP0390849A4 (en) | Methyl cellulose pharmaceutical composition | |
| FR2449686B1 (fr) | Nouvel ester de l'acide 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetique et sa preparation, ainsi que medicament le comprenant et sa preparation | |
| HU203898B (en) | New process for separating bicyclo/3.3.0/octane-3,7-dione-2-carboxylic acid esters and 7-monoketal antipodes of them |